AFT Forsyth & Company’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$532K Sell
4,206
-5
-0.1% -$633 0.27% 66
2025
Q1
$539K Buy
4,211
+2
+0% +$256 0.29% 74
2024
Q4
$556K Sell
4,209
-153
-4% -$20.2K 0.27% 76
2024
Q3
$635K Sell
4,362
-32
-0.7% -$4.66K 0.31% 71
2024
Q2
$603K Buy
4,394
+30
+0.7% +$4.12K 0.3% 76
2024
Q1
$599K Buy
4,364
+108
+3% +$14.8K 0.34% 71
2023
Q4
$578K Sell
4,256
-387
-8% -$52.6K 0.36% 71
2023
Q3
$568K Sell
4,643
-5
-0.1% -$611 0.42% 64
2023
Q2
$590K Sell
4,648
-385
-8% -$48.9K 0.42% 65
2023
Q1
$650K Buy
5,033
+56
+1% +$7.23K 0.5% 60
2022
Q4
$653K Buy
4,977
+141
+3% +$18.5K 0.56% 57
2022
Q3
$566K Buy
4,836
+115
+2% +$13.5K 0.51% 59
2022
Q2
$555K Buy
4,721
+1
+0% +$118 0.45% 64
2022
Q1
$615K Sell
4,720
-68
-1% -$8.86K 0.39% 71
2021
Q4
$731K Buy
4,788
+31
+0.7% +$4.73K 0.38% 80
2021
Q3
$769K Buy
4,757
+60
+1% +$9.7K 0.41% 73
2021
Q2
$769K Buy
4,697
+65
+1% +$10.6K 0.41% 83
2021
Q1
$697K Buy
4,632
+30
+0.7% +$4.51K 0.42% 83
2020
Q4
$697K Buy
4,602
+95
+2% +$14.4K 0.44% 81
2020
Q3
$610K Buy
4,507
+331
+8% +$44.8K 0.45% 70
2020
Q2
$571K Buy
4,176
+75
+2% +$10.3K 0.48% 69
2020
Q1
$442K Sell
4,101
-53
-1% -$5.71K 0.44% 76
2019
Q4
$501K Buy
4,154
+125
+3% +$15.1K 0.38% 87
2019
Q3
$401K Sell
4,029
-120
-3% -$11.9K 0.33% 99
2019
Q2
$453K Hold
4,149
0.37% 88
2019
Q1
$464K Hold
4,149
0.4% 89
2018
Q4
$400K Sell
4,149
-90
-2% -$8.68K 0.4% 88
2018
Q3
$517K Hold
4,239
0.43% 85
2018
Q2
$466K Sell
4,239
-90
-2% -$9.89K 0.41% 90
2018
Q1
$462K Hold
4,329
0.43% 85
2017
Q4
$462K Buy
+4,329
New +$462K 0.45% 76
2013
Q3
$132K Buy
1,884
+744
+65% +$52.1K 0.17% 126
2013
Q2
$66K Buy
+1,140
New +$66K 0.09% 148